As an emergency physician with decades of frontline experience, Dr. Tom Vo, CEO & Chairman of the Board of Nutex Health Inc., witnessed firsthand the inefficiencies that often compromise patient care within traditional hospital systems. Long wait times, limited physician access, and impersonal treatment models highlighted the need for a different approach—one centered on accessibility, efficiency, and compassionate, individualized care.

Driven by this vision, Dr. Vo pioneered the micro-hospital model, a smaller-scale hospital with the clinical capabilities and ancillary services of a traditional hospital, designed to deliver both inpatient and outpatient care without the congestion, complexity, or constraints of large healthcare systems. By operating on a more efficient footprint, micro-hospitals can be built faster and located closer to the communities they serve, significantly improving convenience and access for patients.

This vision became reality in 2011 with the founding of Nutex Health Inc. Under Dr. Vo’s leadership, Nutex Health has since opened and operated 27 micro-hospitals and emergency departments across 12 states, redefining how high-acuity, patient-centered healthcare can be delivered at the community level.

SME BUSINESS REVIEW reached out to Dr. Vo for an interview to understand the evolution of the micro-hospital model, the operational philosophy behind Nutex Health, and how the organization is working to expand access to high-quality, patient-centered care across underserved and rapidly growing communities in the United States. Here’s what he had to say.

Interview Highlights

As a publicly traded healthcare brand, how does Nutex Health define its market identity and value proposition within the broader healthcare industry?

Nutex Health defines itself as a next-generation, community-centered healthcare provider that bridges the gap between traditional hospital systems and urgent/emergency care. As a publicly traded company, Nutex operates at the intersection of high-acuity care, operational efficiency, and patient-centric design, with a distinctive focus on the micro-hospital model.

Rather than competing directly with large legacy hospital systems on scale, Nutex differentiates itself through agility, proximity, and specialization, positioning it as a strategic alternative to overcrowded, capital-intensive healthcare delivery models. The company’s identity is rooted in delivering hospital-level care closer to where patients live, without sacrificing quality, safety, or clinical capability.

This model enables Nutex to deliver hospital-grade care in a more accessible, patient-friendly environment, reducing reliance on distant or overburdened tertiary hospitals. This allows the company to pursue controlled growth, market-by-market expansion, and strategic capital allocation, an essential attribute for a public company operating in capital-constrained environments.

In terms of market positioning, Nutex is viewed as an operator that understands healthcare delivery from the inside out.

What can you tell us about Nutex Health’s coordinated portfolio of assets, and how does it enable the company to deliver high-quality, cost-effective care and ensure patient satisfaction?

Nutex Health operates a strategically integrated portfolio of healthcare assets designed to deliver hospital‑level care more efficiently, more accessibly, and with a superior patient experience. Rather than relying on a single asset class, Nutex’s model is built around coordination, clinical alignment, and operational discipline, allowing each component to reinforce the others.

This integrated structure enables Nutex to control quality, optimize costs, and maintain consistency across markets, which are key differentiators in today’s fragmented healthcare landscape.

This alignment ensures that care delivery decisions are grounded in real-world clinical experience rather than administrative abstraction.

Impact:

1) Improved care quality and safety

2) Stronger physician engagement and retention

3) More consistent patient experiences across sites

This structure allows Nutex to capture economies of scale while preserving site-level agility.

What initiatives has Nutex Health undertaken to build long-lasting partnerships with local physicians and solidify its role in the healthcare ecosystem?

Nutex Health views local physicians as core partners in the delivery of community-based care. The company’s initiatives are intentionally designed to foster alignment, trust, and long-term collaboration, while reinforcing its role as a complementary, high-acuity provider within the broader healthcare ecosystem.

At the foundation of Nutex’s approach is a physician-alignment culture. The company prioritizes clinical insight in both strategic and operational decision-making.

Key initiatives include:

1) Meaningful physician leadership roles at the facility and enterprise level

2) Clinical autonomy in care delivery and workflow design

3) Direct physician input into staffing models, facility layout, and service offerings

This model resonates strongly with community physicians, particularly those frustrated by bureaucratic constraints in traditional hospital systems. By empowering physicians rather than marginalizing them, Nutex builds credibility and long-term engagement.

Rather than imposing rigid system-wide protocols, Nutex balances consistency with local customization, allowing physicians to practice medicine in ways that reflect community expectations and professional judgment.

While Nutex provides centralized support for services such as:

1) Compliance and regulatory oversight

2) Revenue cycle management

3) IT and analytics

4) Supply chain and purchasing

5) Marketing and business development

These services preserve clinical decision-making at the local level, allowing physicians to maintain ownership of patient care while benefiting from enterprise-level resources.

Through these initiatives, Nutex Health has established itself as:

1) A trusted partner to community physicians

2) A complementary provider to hospitals and health systems

3) A patient-focused access point for high-acuity care

4) A physician-aligned public healthcare company

How have Nutex Health’s recent micro-hospital reopenings across states been planned and executed, and what impact have they had?

In late 2025 and early 2026, Nutex Health successfully reopened three dormant micro‑hospitals -- Archview ER & Hospital in St. Louis, Missouri, Red River ER & Hospital in Sherman, Texas, and Bayou City ER & Hospital in Houston, Texas. Each of these facilities had been closed for 12 months or longer under prior ownership and management.

The common challenge across all three locations was a legacy operating model that was heavily ER‑centric, with limited ability to convert emergency visits into appropriate inpatient admissions. In addition, reimbursement models and revenue cycle execution were suboptimal, resulting in underutilized hospital capacity and poor financial performance.

Nutex Health approached these reopenings with a fundamentally different strategy:

Inpatient Operating Model: Rather than relying primarily on ER volume, Nutex repositioned each facility to maximize appropriate inpatient admissions, fully leveraging the “four walls of the hospital” to improve acuity mix, length of stay, and reimbursement.

Targeted Business Development: Leadership teams worked closely with local physicians, specialists, and referral sources to build sustainable inpatient pipelines tailored to each market.

Improved Reimbursement and Collections: Nutex implemented disciplined payer strategies and significantly enhanced collections through the Independent Dispute Resolution (IDR) process, addressing reimbursement gaps that had previously constrained performance.

Experienced Clinical and Administrative Teams: Each reopening was supported by teams trained in Nutex’s operating model, allowing for rapid execution and operational stability despite the facilities having been offline for extended periods.

While these hospitals are newly reopened, early operating data is encouraging. Clinicians and staff have demonstrated a strong ability to convert ER encounters into medically appropriate inpatient admissions, reinforcing the effectiveness of Nutex’s inpatient‑focused model. The initial results support management’s confidence that formerly underperforming or idle assets can be reactivated efficiently and positioned for sustainable growth under Nutex’s disciplined operational framework.

Collectively, these reopenings highlight Nutex Health’s ability to identify distressed healthcare assets, implement proven operational strategies, and quickly restore clinical relevance and financial viability, creating meaningful value across diverse markets.

How does Nutex Health plan to capitalize on major trends in the healthcare market?

Nutex Health’s strategy is deliberately aligned with several powerful, long‑term trends shaping the U.S. healthcare market. Rather than pursuing scale for its own sake, the company focuses on targeted growth, operational efficiency, and physician alignment to create durable value.

Shift Toward Lower‑Cost, High‑Acuity Care Settings: As payors, employers, and patients continue to seek alternatives to large, high‑cost health systems, Nutex’s micro‑hospital model is well-positioned to deliver high‑acuity emergency and inpatient care at a lower cost structure. By operating purpose‑built facilities with efficient footprints, Nutex can provide hospital‑level services closer to patients while maintaining flexibility and capital discipline.

Demand for Faster Access and Improved Patient Experience: Patients increasingly expect timely, concierge‑level care. Nutex hospitals are designed to reduce wait times, streamline patient flow, and support strong clinical outcomes. This focus on access, convenience, and patient satisfaction supports volume growth, physician loyalty, and community relevance in competitive markets.

Growth of Physician Alignment and Care Coordination: Physician engagement remains a critical differentiator. Nutex is expanding its network of Independent Practice Associations (IPAs) to strengthen physician alignment, improve referral optimization, and enhance continuity of care. These IPAs also position Nutex to participate more effectively in emerging value‑based, risk‑shared, and hybrid reimbursement models.

Increasing Emphasis on Operational Efficiency and Margin Discipline: With ongoing reimbursement pressure and labor constraints across healthcare, Nutex is investing in automation and AI‑enabled processes across clinical documentation, revenue cycle management, staffing optimization, and administrative workflows. These efforts are designed to reduce variability, lower unit costs, and improve financial resilience without compromising quality.

Focus on Capital Discipline and Scalable Growth: Healthcare investors are increasingly rewarding companies that demonstrate return‑focused expansion and balance‑sheet discipline. Nutex’s approach—opening 3–5 hospitals annually, reinvesting in high‑performing assets, and expanding IPAs selectively—reflects a commitment to growth that is scalable, measurable, and aligned with long‑term shareholder value.

By aligning its operating model with these macro trends—cost efficiency, access, physician partnership, automation, and disciplined capital allocation—Nutex Health believes it is well-positioned to navigate industry volatility while building a resilient, differentiated healthcare platform. This strategy allows Nutex to adapt as the healthcare landscape evolves, while staying focused on high‑quality, patient‑centered care and sustainable financial performance.

What differentiates Nutex Health in the healthcare management and operations market?

Nutex Health stands apart in the healthcare management and operations market through its physician-led, vertically integrated, and capital-efficient micro-hospital platform, delivering hospital-level care with greater agility, stronger clinical alignment, and a superior patient experience.

Unlike traditional healthcare operators that manage large, capital-intensive hospital systems, Nutex is built around the micro-hospital model, providing hospital-level care in a smaller, more efficient footprint. This model allows Nutex to operate with greater agility, adapt to local market needs, and deliver high-acuity care without the inefficiencies of large-scale hospital operations.

Nutex is not simply an operator or a management services provider, but an integrated owner-operator with centralized control over:

1) Clinical operations and governance

2) Revenue cycle management

3) Legal, regulatory compliance and accreditation

4) Facility design, development, and optimization

5) Financial reporting and performance oversight

6) Marketing and business development

7) IT 

This vertical integration provides better alignment, faster decision-making, and stronger accountability across facilities, resulting in consistent execution and improved operational outcomes.

Lastly, founded by emergency physicians, Nutex’s operations are driven by frontline clinical experience, not purely administrative priorities.

Distinctive elements include:

1) Meaningful physician leadership roles

2) Clinical autonomy embedded into workflows

3) Operating decisions shaped by real-world patient care demands

This approach differentiates Nutex from management firms that treat clinical services as an outsourced function, enhancing physician engagement, care quality, and patient trust.

How have Nutex Health’s stock performance and financial metrics influenced its strategic decisions and investor relations?

Nutex Health’s stock performance and core financial metrics have influenced our decision-making and how we engage with investors.

Operating in a volatile and evolving healthcare environment has reinforced the importance of discipline, transparency, and long‑term value creation.

From a strategic standpoint, market performance has sharpened our focus on:

Capital discipline and return on invested capital, prioritizing projects that deliver durable cash flow and scalable margins rather than growth for growth’s sake.

Reinvestment over expansion when appropriate, particularly enhancing infrastructure, service lines, and throughput at existing hospitals where returns are more predictable.

Operational efficiency, especially through automation and AI initiatives, to improve margins, reduce variability, and strengthen performance resilience across economic and reimbursement cycles.

Balanced growth, ensuring hospital and IPA expansion aligns with liquidity, leverage tolerance, and shareholder value considerations.

From an investor relations perspective, Nutex’s experience in the public markets has underscored the importance of:

Clear, consistent financial communication, helping investors understand normalized performance, non‑GAAP adjustments, and the long‑term earnings power of the platform.

Proactive expectation management, particularly during periods of regulatory change, reimbursement pressure, or broader market volatility affecting healthcare equities.

Transparency around capital allocation priorities, including reinvestment, growth initiatives, and balance sheet management.

Long‑term orientation, reinforcing how near‑term stock fluctuations do not alter management’s commitment to building a scalable, physician‑aligned healthcare platform with sustainable returns.

Overall, Nutex Health views public market feedback as an important input, but not the sole driver of strategy. Stock performance and financial metrics shape execution and communication, while decisions remain grounded in long‑term fundamentals, operational rigor, and disciplined growth. This approach has helped strengthen credibility with investors and align shareholder expectations with the company’s long‑term vision.

What are Nutex Health’s plans and outlook for the next five years?

Over the next five years, Nutex Health plans to execute a disciplined, multi‑pronged growth strategy focused on expanding access, enhancing operational efficiency, and driving sustainable profitability. Key priorities include:

Measured Hospital Expansion: Nutex expects to continue opening approximately 3–5 hospitals per year, targeting markets where our micro‑hospital and specialty care model can deliver high‑quality, cost‑effective care while addressing unmet community needs.

Reinvestment in Existing Facilities: We plan to strategically reinvest in our current hospital portfolio, especially critical infrastructure and service line enhancements, to support growth in both emergency room and inpatient volumes, improve patient throughput, and maximize returns on existing assets.

Operational Automation and AI Adoption: Nutex will continue to invest in AI‑driven and automated processes across clinical, administrative, and revenue cycle operations. These initiatives are designed to enhance efficiency, reduce costs, improve accuracy, and allow clinical teams to focus more directly on patient care.

Expansion of Independent Practice Associations (IPAs): We expect to open 1–2 IPAs per year in select markets. These IPAs will complement our hospital footprint by strengthening physician alignment, improving care coordination, and expanding participation in value‑based and risk‑shared reimbursement models.

Collectively, these initiatives position Nutex Health for scalable, capital‑disciplined growth, with an emphasis on leveraging our existing platform, deepening physician partnerships, and utilizing technology to drive operating leverage. Our outlook reflects confidence in the durability of our business model and our ability to adapt to a rapidly evolving healthcare landscape while continuing to deliver high‑quality, patient‑centered care.

TOM VO, M.D., MBA | CEO & CHAIRMAN OF THE BOARD 

Dr. Tom Vo brings more than 30 years of expertise in the Business of Medicine to Nutex Health. He is residency trained in emergency medicine and has worked in busy hospitals and emergency centers throughout Texas. Additionally, he has been instrumental in the start-up and management of over 30 Specialty Hospitals and Emergency Centers throughout the US. He is recognized by his contemporaries as one of the pioneers and leaders in the field. In 2020, Dr. Vo received the prestigious EY Entrepreneur Of The Year® award, where he went on to become the National Finalist. In 2025, he was awarded ‘Most Admired CEO’ by the Houston Business Journal.

Dr. Vo’s affinity for helping others inspired him to study medicine. He graduated from Kent State in 1992 and Northeastern Ohio University’s College of Medicine in 1996. In 1999, he completed his Emergency Medicine Residency at William Beaumont Hospital in Royal Oak, MI. In 2004, Dr. Vo received an MBA from Rice University to learn more about the business side of medicine.